SLAB:NASDAQSilicon Laboratories, Inc. Analysis
Data as of 2026-09-01 - not real-time
$219.05
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
Silicon Laboratories Inc. is priced at $219.05 and its moving averages line up in bullish order, the shorter sitting above the longer. RSI sits at 56.5, which reads as neutral, and MACD momentum is bullish. Price has been bracketed by support at $217.61 and resistance at $219.75.
On valuation the read is overvalued — earnings multiple of 50.2 versus a 35.8 sector average, above the peer group. Revenue is growing at 18.3% on a -4.6% profit margin.
Risk scores 3 out of 10, which is low for this asset class. With 30-day volatility of 3.3%, a beta of 0.59 and a maximum drawdown of 17.8%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — hold in the near term, sell further out, at 5/10 long-term conviction.
On valuation the read is overvalued — earnings multiple of 50.2 versus a 35.8 sector average, above the peer group. Revenue is growing at 18.3% on a -4.6% profit margin.
Risk scores 3 out of 10, which is low for this asset class. With 30-day volatility of 3.3%, a beta of 0.59 and a maximum drawdown of 17.8%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — hold in the near term, sell further out, at 5/10 long-term conviction.
Top Market Events
AUSTIN, Texas AP — AUSTIN, Texas AP — Silicon Laboratories Inc.Silicon Laboratories NasdaqGS: SLAB announced the BG2B Bluetooth Low Energy SoC for IoT devices, targeting higher power...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 192.10
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 50.2 versus sector average of 35.8
- Trading above the 200-day average of 192.10
Long Term
> 3 yearsCautious
Model confidence: 5/10
Key Factors
- P/E of 50.2 versus sector average of 35.8
- Negative profit margin of -4.6%
- Negative return on equity of -3.6%
Key Metrics & Analysis
Financial Health
Revenue Growth18.30%
Profit Margin-4.57%
P/E Ratio50.2
ROE-3.63%
ROA-2.19%
P/B Ratio6.7
Op. Cash Flow$33.1M
Free Cash Flow$-13706625
Industry P/E35.8
Technical Analysis
TrendBullish
RSI56.5
Support$217.61
Resistance$219.75
MA 20$218.62
MA 50$218.20
MA 200$192.10
MACDBullish
VolumeIncreasing
Fear & Greed Index94.79
Valuation
Fair Value$30.62
Target Price$222.86
Upside/Downside1.74%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.59
Volatility3.32%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
ZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKWTS
Watts Water Technologies, Inc.
STOCKAMZN
Amazon.com, Inc.
STOCKBLK
BlackRock, Inc.
STOCKUSFD
US Foods Holding Corp.
STOCKUSAC
USA Compression Partners, LP
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.